|
⚲
|
| Keyboard |
| Kirk Allan
✚
|
|
|---|---|
| CIK # | 0001995409 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001995409] | |
| 4 | [0001995409] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kirk Allan | |
| Tokai Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tokai Pharmaceuticals Inc ELDN
Common Stock
|
2026-01-10 | Option exercise | 3,430 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
|
2026-01-10 | Option exercise | 3,430 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
|
2025-01-10 | Grant | 3,430 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
|
2025-01-10 | Grant | 30,870 | $0.00 | |
|
Tokai Pharmaceuticals Inc ELDN
Stock Option (Right to Buy) · derivative
|
2023-10-02 | Grant | 150,437 | $1.55 | 233,177 |